Skip to main navigation Skip to search Skip to main content

Cardiovascular MRImaging in Cardio-oncology

Research output: Contribution to journalReview articlepeer-review

Abstract

Patients with cancer are subject to short-term and long-term adverse cardiovascular outcomes from cancer therapies. It is important to identify patients at risk for cardiotoxicity so that appropriate therapy can be instituted early. Cardiovascular magnetic resonance (MR) imaging is emerging as a promising imaging modality with unique applications beyond standard left-ventricular systolic function assessment. It can provide comprehensive evaluation of most cardiac structures in one setting. This article provides an overview of cardiac MR imaging in cardio-oncology.

Original languageEnglish (US)
Pages (from-to)105-116
Number of pages12
JournalMagnetic Resonance Imaging Clinics of North America
Volume23
Issue number1
DOIs
StatePublished - Feb 1 2015

Bibliographical note

Publisher Copyright:
© 2015 Elsevier Inc.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Cardio-oncology
  • Cardiotoxicity
  • Cardiovascular magnetic resonance imaging
  • Radiation-induced heart disease

Fingerprint

Dive into the research topics of 'Cardiovascular MRImaging in Cardio-oncology'. Together they form a unique fingerprint.

Cite this